Ikarian Capital’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-70,277
| Closed | -$794K | – | 112 |
|
|
2022
Q2 | $794K | Sell |
70,277
-143,436
| -67% | -$1.62M | 0.14% | 51 |
|
|
2022
Q1 | $6.39M | Buy |
213,713
+169,777
| +386% | +$5.08M | 0.84% | 16 |
|
|
2021
Q4 | $1.16M | Buy |
+43,936
| New | +$1.16M | 0.17% | 65 |
|
|
2021
Q1 | – | Sell |
-34,553
| Closed | -$1.21M | – | 228 |
|
|
2020
Q4 | $1.21M | Sell |
34,553
-35,000
| -50% | -$1.22M | 0.05% | 87 |
|
|
2020
Q3 | $1.67M | Sell |
69,553
-98,500
| -59% | -$2.36M | 0.12% | 64 |
|
|
2020
Q2 | $3.08M | Hold |
168,053
| – | – | 0.24% | 37 |
|
|
2020
Q1 | $2.62M | Buy |
168,053
+133,053
| +380% | +$2.08M | 0.2% | 31 |
|
|
2019
Q4 | $749K | Buy |
+35,000
| New | +$749K | 0.12% | 33 |
|